Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Pheretima aspergillum decoction significantly increased the asthma incubation period and decreased serum IL-4 and LTB4 levels in guinea pigs [PMID:31531069]; it also relieved asthma in mouse models via NF-κB inhibition [PMID:27184188].
Oral administration in rats reduced cerebral infarction areas in the cortex and striatum and reduced neurological deficit scores [PMID:24082328].
Extract attenuated high-KCl-induced mitochondrial injury and pro-fibrotic events in cardiomyoblast cells [PMID:31066208].
A systematic review and meta-analysis investigated antifibrotic effects, though results were noted as controversial [PMID:36618931].
Extract stimulated osteoblast proliferation, differentiation, and matrix calcium deposition in a dose-dependent manner [PMID:25387689].
Synthèse des preuves
Sources PubMed
- 1.PMID: 25387689 (2014) — Earthworm (Pheretima aspergillum) extract stimulates osteoblast activity and inhibits osteoclast differentiation. · BMC complementary and alternative medicine
- 2.PMID: 36618931 (2022) — Effect of Pheretima aspergillum on reducing fibrosis: A systematic review and meta-analysis. · Frontiers in pharmacology
- 3.PMID: 39893778 (2025) — A strategy integrated DNA barcoding with metabolomics for screening distinguishable combinatorial chemical quality marker between Pheretima aspergillum and Pheretima vulgaris Chen. · Journal of pharmaceutical and biomedical analysis
- 4.PMID: 37018956 (2023) — A novel strategy to identify the species-specific peptide biomarkers in Pheretima aspergillum (E. Perrier) based on enzymatic digestion followed by LC-MS/MS methods. · Journal of pharmaceutical and biomedical analysis
- 5.PMID: 26681024